Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A.

Imagen de Leonardo Valdivieso-Torres
PDF versionPDF version
TítuloComparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A.
Publication TypeJournal Article
Year of Publication2012
AutoresMazari, PM, Argaw, T, Valdivieso, L, Zhang, X, Marcucci, KT, Salomon, DR, Wilson, CA, Roth, MJ
JournalVirology
Volume427
Issue2
Pagination118-26
Date Published2012 Jun 5
ISSN1096-0341
Palabras claveAmino Acid Sequence, Animals, Cats, Cell Line, Endogenous Retroviruses, Gene Expression Regulation, Viral, Humans, Leukemia Virus, Feline, Mutation, Protein Binding, Receptors, Cell Surface, Recombinant Proteins, Swine, Viral Envelope Proteins, Viral Tropism, Virus Internalization
Abstract

In vitro screening of randomized FeLV Envelope libraries identified the CP isolate, which enters cells through HuPAR-1, one of two human receptors utilized by porcine endogenous retrovirus-A (PERV-A), a distantly related gammaretrovirus. The CP and PERV-A Envs however, share little amino acid homology. Their receptor utilization was examined to define the common receptor usage of these disparate viral Envs. We demonstrate that the receptor usage of CP extends to HuPAR-2 but not to the porcine receptor PoPAR, the cognate receptor for PERV-A. Reciprocal interference between virus expressing CP and PERV-A Envs was observed on human cells. Amino acid residues localized to within the putative second extracellular loop (ECL-2) of PAR-1 and PAR-2 are found to be critical for CP envelope function. Through a panel of receptor chimeras and point mutations, this area was also found to be responsible for the differential usage of the PoPAR receptor between CP and PERV-A.

DOI10.1016/j.virol.2012.02.012
Alternate JournalVirology
PubMed ID22405627
PubMed Central IDPMC3572736
Grant ListR01 AI052349 / AI / NIAID NIH HHS / United States
R01 CA049932-17 / CA / NCI NIH HHS / United States
R01 CA049932-18 / CA / NCI NIH HHS / United States
R01 CA049932-19 / CA / NCI NIH HHS / United States
R01 CA049932-19S1 / CA / NCI NIH HHS / United States
R01 CA49932 / CA / NCI NIH HHS / United States
T32 GM008360 / GM / NIGMS NIH HHS / United States